BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10228492)

  • 21. Primary central nervous system lymphoma.
    Bhagavathi S; Wilson JD
    Arch Pathol Lab Med; 2008 Nov; 132(11):1830-4. PubMed ID: 18976024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic silencing of multiple genes in primary CNS lymphoma.
    Chu LC; Eberhart CG; Grossman SA; Herman JG
    Int J Cancer; 2006 Nov; 119(10):2487-91. PubMed ID: 16858686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytology of primary central nervous system neoplasms in cerebrospinal fluid specimens.
    Chhieng DC; Elgert P; Cohen JM; Jhala NC; Cangiarella JF
    Diagn Cytopathol; 2002 Apr; 26(4):209-12. PubMed ID: 11933264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant lymphomas involving the central nervous system--a morphological and immunohistochemical study of 32 cases.
    Simon J; Jones EL; Trumper MM; Salmon MV
    Histopathology; 1987 Apr; 11(4):335-49. PubMed ID: 3596473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary Ki-1 lymphoma in the central nervous system.
    Kawamura T; Inamura T; Ikezaki K; Miyazono M; Ishihara S; Fukui M
    J Clin Neurosci; 2001 Nov; 8(6):574-7. PubMed ID: 11683612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
    Meusers P; Brittinger G
    Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classification, pathogenesis and molecular pathology of primary CNS lymphomas.
    Paulus W
    J Neurooncol; 1999 Jul; 43(3):203-8. PubMed ID: 10563424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-ALA-induced fluorescence as a marker for diagnostic tissue in stereotactic biopsies of intracranial lymphomas: experience in 41 patients.
    Kiesel B; Millesi M; Woehrer A; Furtner J; Bavand A; Roetzer T; Mischkulnig M; Wolfsberger S; Preusser M; Knosp E; Widhalm G
    Neurosurg Focus; 2018 Jun; 44(6):E7. PubMed ID: 29852770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Programmed Cell Death Ligand 1 Expression in Primary Central Nervous System Lymphomas: A Clinicopathological Study.
    Hayano A; Komohara Y; Takashima Y; Takeya H; Homma J; Fukai J; Iwadate Y; Kajiwara K; Ishizawa S; Hondoh H; Yamanaka R
    Anticancer Res; 2017 Oct; 37(10):5655-5666. PubMed ID: 28982883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular analysis of primary central nervous system and primary intraocular lymphomas.
    Tuaillon N; Chan CC
    Curr Mol Med; 2001 May; 1(2):259-72. PubMed ID: 11899075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project.
    Cancer; 1982 May; 49(10):2112-35. PubMed ID: 6896167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-Hodgkin lymphomas of the central nervous system. Clinico-pathologic and immunohistochemical study of 147 cases.
    Ferracini R; Pileri S; Bergmann M; Sabattini E; Rigobello L; Gambacorta M; Galli C; Manetto V; Frank G; Godano U
    Pathol Res Pract; 1993 Apr; 189(3):249-60. PubMed ID: 8332570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary central nervous system lymphoma: a review.
    McAllister LD
    Curr Neurol Neurosci Rep; 2002 May; 2(3):210-5. PubMed ID: 11936999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central nervous system lymphoma in the acquired immunodeficiency syndrome.
    Morgello S; Petito CK; Mouradian JA
    Clin Neuropathol; 1990; 9(4):205-15. PubMed ID: 2171824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central nervous system involvement in indolent lymphomas.
    Spectre G; Gural A; Amir G; Lossos A; Siegal T; Paltiel O
    Ann Oncol; 2005 Mar; 16(3):450-4. PubMed ID: 15642707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acquired immunodeficiency syndrome-associated lymphomas: clinical, pathologic, immunologic, and viral characteristics of 111 cases.
    Ioachim HL; Dorsett B; Cronin W; Maya M; Wahl S
    Hum Pathol; 1991 Jul; 22(7):659-73. PubMed ID: 2071112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary central nervous system lymphomas in immunocompetent patients.
    Guinto G; Félix I; Aréchiga N; Arteaga V; Kovacs K
    Histol Histopathol; 2004 Jul; 19(3):963-72. PubMed ID: 15168358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary malignant lymphomas of the central nervous system: a histological and immunohistological study of 12 cases.
    Allegranza A; Mariani C; Giardini R; Brambilla MC; Boeri R
    Histopathology; 1984 Sep; 8(5):781-91. PubMed ID: 6549172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histopathology, pathogenesis and molecular genetics in primary central nervous system lymphomas.
    Nakamura M; Shimada K; Ishida E; Konishi N
    Histol Histopathol; 2004 Jan; 19(1):211-9. PubMed ID: 14702189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-cell posttransplant lymphoproliferative disorder isolated to the central nervous system is Epstein-Barr virus positive and lacks p53 and Myc expression by immunohistochemistry.
    Sundin A; Grzywacz BJ; Yohe S; Linden MA; Courville EL
    Hum Pathol; 2017 Mar; 61():140-147. PubMed ID: 27993575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.